About: Minimal residual disease monitoring by flow cytometry

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Minimal residual disease monitoring by flow cytometry Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2003 (uk) مقالة علمية تنشرت ف 1 دجنبر 2003 (ary) im Dezember 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2003 (ast) scientific article published on 01 December 2003 (en)
publication date	wds:Q79236551-999656A3-6A4C-4906-AACA-73C0A909F11B
publication date	2003-12-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q79236551-1177BEC6-E613-4655-96CB-26453CC631E0 wds:Q79236551-1819A6A6-B790-43B0-BB95-4A43FE272D71 wds:Q79236551-1F41BAA1-CC26-4A10-83EE-2041B254270B wds:Q79236551-1FF90840-34D7-41A7-9A6E-EFD36AF82B53 wds:Q79236551-22ED0859-2CD1-4969-BE37-EFE8D5BBE73F wds:Q79236551-3021CA67-7E13-46EF-B1A3-3093CD45B5C6 wds:Q79236551-32500B42-4DF4-4B30-976A-E49C1BD2B912 wds:Q79236551-34517B7E-4AC7-465F-A374-71F54181EE36 wds:Q79236551-367267D0-FE1D-4EC5-AC32-79BD33C6B8AE wds:Q79236551-3CAEC38B-EC2D-43D9-8EEA-FB3F94FEBB5A wds:Q79236551-4F7F17B0-E8A9-4D7E-942D-02B2782C8B6F wds:Q79236551-4FB6CA3F-4DA4-4932-BD14-2A4E759C4739 wds:Q79236551-53A00C80-6FBF-439A-B9E3-69BA86F97457 wds:Q79236551-56394ECF-1B9E-46D9-B20A-268EB8D12F3C wds:Q79236551-565AEF2E-B95F-4B8E-AB63-FD5C8378C08C wds:Q79236551-5A216A01-BA4B-4F2F-9410-5F2CE55F4109 wds:Q79236551-5E34F3DD-9502-4FF5-A8B6-89CB802D6ADD wds:Q79236551-611B2F32-F0B3-4E0C-B00D-F2FC38B126D5 wds:Q79236551-63C84B2F-1DFC-425D-B961-49227BB7EF63 wds:Q79236551-66F8734A-D70F-4FE7-8A96-1F5E0E1C3CDC wds:Q79236551-71C99B75-F889-4E8B-8401-59AFAFDE81D3 wds:Q79236551-72A20499-3BE2-4F2F-81F6-5B06A70D0673 wds:Q79236551-758E8566-0FB4-498E-B83F-A3C15D5951C7 wds:Q79236551-76BEF35C-CF25-4199-949D-1274DB87A363 wds:Q79236551-7A4F2DE1-AF2A-4803-960D-89F15B7EE855 wds:Q79236551-8C686A5D-AF3A-4557-BF9E-9217C8059B57 wds:Q79236551-9104D97D-B741-4BE8-87F0-423CC0F569D3 wds:Q79236551-986D91DC-F2EF-4D56-9663-5902EEF04C5A wds:Q79236551-9A854015-4A88-481F-8EE5-28C38B04FDE8 wds:Q79236551-9B103585-E35A-49B9-9717-70C37E1ADD16 wds:Q79236551-9CA9F09A-C783-4C9E-823F-206B278DCF24 wds:Q79236551-A1D46E81-2063-4232-B481-AD5F37EB2690 wds:Q79236551-A20546AB-BE69-448B-ADEF-5D32FEB5914A wds:Q79236551-A97BD268-650D-4547-96C6-64CF698BCB22 wds:Q79236551-ADC37D82-78C6-4F63-BE0C-8309164755C0 wds:Q79236551-AFBCF38F-99CD-4256-AB0D-6C47ED856908 wds:Q79236551-B725803F-D751-4892-A7D5-53E0FE0C284B wds:Q79236551-B733A08B-0E49-424A-AAAD-C6A9A7417574 wds:Q79236551-BDA3C40A-A652-404A-BE27-D83482C3BA0C wds:Q79236551-BE24C3B2-F549-4DFB-8AF1-0482B5A56A94 wds:Q79236551-BEF762B0-5B20-47EF-9B6A-970C5D346A65 wds:Q79236551-C33A3343-F40F-4C67-A864-8B0B1C41117B wds:Q79236551-C6FFCBB2-679A-4FA5-B489-434A234FB8D8 wds:Q79236551-D12BC7BC-9DD0-46BF-8214-4F46772FF63B wds:Q79236551-DE6D434A-96F8-4721-A76E-7EA1522CA4B3 wds:Q79236551-DEDA5F48-BE42-4CA7-987E-25FFC6FC077F wds:Q79236551-E22B1646-72CB-48D6-9400-D1CC751059AA wds:Q79236551-E2B25967-6727-4F04-9061-50842BA07F88 wds:Q79236551-E3B2AAC0-3696-46B8-89B3-DA6AC7A674A1 wds:Q79236551-E5D637EB-25AA-43C9-88EA-2681B361718D wds:Q79236551-FAFC1D77-7884-4A7C-A0F2-365680475AF0 wds:Q79236551-FCF4D188-7708-45B9-BBDA-6F0E418A1746 wds:Q79236551-FD53CCEF-1365-49C6-BAFC-64311257611A wds:Q79236551-FED73814-5A3A-4D20-9CBC-CABAE4AE484C wds:Q79236551-FF2163D2-1971-42BA-A8FF-935F66A5795D
cites work	Detection of minimal residual disease in acute leukemia by flow cytometry Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Prediction of relapse of pediatric acute myeloid leukemia by use of multidimensional flow cytometry. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value. Minimal residual disease in leukaemia patients Determination of minimal residual disease in leukaemia patients Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia Detection of rare cells at a frequency of one per million by flow cytometry Childhood acute lymphoblastic leukaemia--current status and future perspectives Immunophenotypical detection of minimal residual disease in acute leukemia. Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL) Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software